Public Profile

Renata PLC

Renata PLC, commonly known as Renata Limited, is a leading pharmaceutical company headquartered in Bangladesh (BD). Established in 1972, Renata has made significant strides in the industry, focusing on the development, manufacturing, and marketing of a diverse range of pharmaceutical products. With a strong presence in both domestic and international markets, the company operates extensively across South Asia and beyond. Renata's core offerings include generic medicines, active pharmaceutical ingredients, and veterinary products, distinguished by their commitment to quality and innovation. The company has achieved notable recognition for its robust research and development capabilities, positioning itself as a trusted name in the pharmaceutical sector. With a dedication to improving healthcare outcomes, Renata PLC continues to expand its market presence while adhering to the highest industry standards.

DitchCarbon Score

How does Renata PLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

22

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

33

Industry Benchmark

Renata PLC's score of 22 is lower than 84% of the industry. This can give you a sense of how well the company is doing compared to its peers.

16%

Let us know if this data was useful to you

Renata PLC's reported carbon emissions

Renata PLC, headquartered in BD, currently does not have publicly available carbon emissions data or specific reduction targets. Without emissions figures, it is challenging to assess their carbon footprint or the scope of their emissions (Scope 1, 2, or 3). However, the company may still be engaged in climate commitments or initiatives within the industry context. As of now, there are no documented reduction initiatives or climate pledges from Renata PLC. This lack of data highlights the importance of transparency in corporate climate strategies and the need for companies to establish measurable targets to contribute effectively to global climate goals.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Renata PLC's primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Renata PLC is in BD, which has a medium grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Renata PLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Similar Organizations

Techno Drugs Ltd.

BD
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Ziska Pharmaceuticals Ltd

BD
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Advent Pharma Ltd.

BD
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Central Pharmaceuticals Ltd.

BD
Pharmaceutical Preparation Manufacturing
Updated 3 days ago

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers